Form 4: Expensify CEO David Barrett Sells Shares Under 10b5-1 Trading Plan

Expensify CEO David Barrett sold a total of 86,584 Class A common shares between January 15th and January 17th, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Expensify CEO David Barrett executed multiple sales of Class A common stock between January 15th and January 17th, 2025.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on August 15, 2024.
• On January 15th, 30,000 shares were sold at a weighted average price of $3.50, with individual prices ranging from $3.25 to $3.40.
• On January 16th, 24,111 shares were sold at a weighted average price of $3.40, with individual prices ranging from $3.34 to $3.46.
• On January 17th, 32,473 shares were sold at a weighted average price of $3.41.
• Following these transactions, David Barrett directly owns 185,289 shares and indirectly owns 2,147,203 shares through the Barrett Trust LLC.

Sentiment

Score: 5

Explanation: The document reports routine stock sales by the CEO under a pre-arranged plan. This is a neutral event and does not indicate any positive or negative sentiment.

Risks

• The sale of shares by the CEO could be perceived negatively by the market, potentially impacting the stock price.
• The reliance on a 10b5-1 trading plan suggests a predetermined strategy for selling shares, which may not reflect the CEO's current outlook on the company's performance.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a standard practice for executives to sell shares without being accused of insider trading.
• The reported share sales are not unusual for a CEO of a publicly traded company, and the volume of shares sold is not particularly large compared to other similar transactions.
• The price range of the sales is within the normal fluctuations of the stock price.

Stakeholder Impact

• The share sales could potentially cause a slight decrease in the stock price due to increased supply, which may impact shareholders.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Expensify, David Barrett, insider trading, Form 4, Rule 10b5-1, stock sale, CEO, share transaction